维普期刊资源整合服务平台（V6.5）

112篇 您的检索式：作者名="Thor AD"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	HER2 and response to paelitaxel in node-positive breast cancer显示文摘	Hayes DF Thor AD Dressier l G	2007	N Engl J Med2007，357，15：	1
2	HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node- positive breast cancer显示文摘	Berry DA Muss HB Thor AD	2000	J Clin Oncol2000，18，20：	1
3	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Hayes DF Thor AD	2002	Semin Oncol2002，29，3：	1
4	c-erbB-2 in breast cancer:Development of a clinically useful marker显示文摘	Hayes DF Thor AD	2002	Semin Oncol2002，29，3：	1
5	Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study显示文摘	Louis DN Egerton S Thor AD	1991	Act Neuropathol1991，81，6：	1
6	HER2 and response to paclitaxel in node-positive breast cancer显示文摘	Hayes DF Thor AD Dressler LG	2007	N Engl J Med2007，357，15：	1
7	p21/WAF1/Cip1 expression in breast cancer: associations with P53 and outcome显示文摘	Thor AD Liu S Moore DH	2000	Breast Cancer Res Treat2000，61，6：	1
8	The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression显示文摘	Wang C Thor AD Moore DH	1998	Clin Cancer Res1998，4，3：	1
9	Ovarian small cell carcinoma:Histogenetic consideration based on immunohistochemical and other findings 显示文摘	Aguirre P Thor AD Scully RE	1989	Am J Clin Pathol1989，92，：	1
10	c-erbB-2 in breast cancer: development of a clinically useful marker显示文摘	Hayes DF Thor AD	2002	Semin Oncol2002，29，3：	1
11	HER2 and response to pa- clitaxel in node-positive breast cancer显示文摘	Hayes DF Thor AD Dressler LG	2007	N EnglJ Med2007，357，15：	1
12	C-erbB-2 in breast cancer development of a clinically useful marker显示文摘	Hayes D F Thor AD	2002	Semin Oncol2002，29，：	1
13	Activation (tyrosine phosphorylation) of Erb B-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer 显示文摘	LIU S EDGERTON S	2000	J Clin Oncol2000，18，：	1
14	Weekly docetaxel and rhumabher combination therapy as first or second line treatment for metastatic breast cancer显示文摘	Thor AD Goldstein LJ	2000	Proc Am Soc Clin Oncol2000，19，：	1
15	c erbB 2 expression and response to adjuvant therapy in women with node positive early breast cancer 显示文摘	Muss HB Thor AD Berry DA	1994	N Engl J Med1994，330，18：	1
16	CerbB-2 expression and responseto adjuvant therapy in women with node-positive early breast cancer显示文摘	Thor AD Berry DA	1994	N Engl J Med1994，330，18：	1
17	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Hayes DF Thor AD	2002	Semin Oncol2002，29，3：	1
18	Subcellular localization of the HER4 intracellular domain,4ICD,identifies distinct prognostic outcomes for breast cancer patients显示文摘	Thor AD Edgerton SM Jones FE	2009	Am J Pathol2009，175，5：	1
19	The overexpression of RHAMM, a hyaluronan binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression显示文摘	Wang C Thor AD Moore DH II	1998	Clin Cancer Res1998，4，3：	1
20	Survival signaling byNotchl : mammalian target of rapamycin (mTOR) -dependentinhibition of p53 显示文摘	Mungamuri SK Yang X Thor AD	2006	Cancer Res2006，66，9：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示